St. Luke's is a 532-bed hospital in Cedar Rapids, Iowa. It was founded in 1884 as Cedar Rapids’ first hospital and is now one of two hospitals in Cedar Rapids, the other being Mercy Medical Center. St. Luke's emergency department treats over 55,000 patients each year and the most cases of trauma in Iowa.

There are 532 beds in St. Luke's Hospital.

During the past decade, St. Luke's Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 33 clinical trials were completed, i.e. on average, 235.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 12 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 28 trials, followed by "National Cancer Institute (NCI)" with 19 trials sponsored, "NRG Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored and "Wake Forest University Health Sciences" with 5 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Hospital" are "Breast Cancer" (13 trials), "Lung Cancer" (9 trials), "Prostate Adenocarcinoma" (5 trials), "Prostate Cancer" (4 trials) and "Breast Adenocarcinoma" (3 trials). Many other conditions were trialed in "St. Luke's Hospital" in a lesser frequency.

Most popular intervention types in "St. Luke's Hospital" are "Drug" (65 trials), "Other" (37 trials), "Radiation" (22 trials), "Biological" (21 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (12 trials), "placebo" (8 trials), "Paclitaxel" (7 trials) and "Questionnaire Administration" (7 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Hospital" are 54 trials for "All" genders, 19 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "St. Luke's Hospital". undefined are not yet recruiting, 8 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 54 completed trials in St. Luke's Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Hospital, 3 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".